Press Releases Choose Year All Items 2026 2025 2024 Search Press Releases Found 21 Results January 26, 2026 LB Pharmaceuticals Initiates Phase 2 ILLUMINATE-1 Trial in Bipolar Depression, Expanding LB-102 Development Program January 21, 2026 LB Pharmaceuticals Appoints Minako Pazdera, J.D., Ph.D. as General Counsel January 12, 2026 LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) January 6, 2026 LB Pharmaceuticals Strengthens Leadership Team with Key Appointments in Corporate Affairs and People & Culture December 10, 2025 LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) December 9, 2025 LB Pharmaceuticals Added to the Russell 2000® and Russell 3000® Indices November 24, 2025 LB Pharmaceuticals Announces Presentation at the Piper Sandler 37th Annual Healthcare Conference November 12, 2025 LB Pharmaceuticals Appoints Kaya Pai Panandiker as Chief Commercial Officer November 12, 2025 LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) November 6, 2025 LB Pharmaceuticals Reports 3Q 2025 Financial Results and Recent Corporate Updates 123»
